Paper42016367
Multicenter Evaluation of Ceftazidime/Avibactam in Pediatric Patients Across the United States: Real-World Insights into the Management of Drug-Resistant Gram-Negative Infections.
Morrisette T and 24 others. Open Forum Infect Dis, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Multicenter Evaluation of Ceftazidime/Avibactam in Pediatric Patients Across the United States: Real-World Insights into the Management of Drug-Resistant Gram-Negative Infections. Papers, record 42016367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42016367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Multicenter Evaluation of Ceftazidime/Avibactam in Pediatric Patients Across the United States: Real-World Insights into the Management of Drug-Resistant Gram-Negative Infections.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18929686 | Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. | J Biomed Inform | 2009 | https://conductscience.org/library/papers/18929686 | PubMed |
| 2 | 33130270 | Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review. | Clin Microbiol Infect | 2021 | https://conductscience.org/library/papers/33130270 | PubMed |
| 3 | 35734203 | Disparities Associated with Sepsis Mortality in Critically Ill Children. | J Pediatr Intensive Care | 2022 | https://conductscience.org/library/papers/35734203 | PubMed |
| 4 | 40019735 | Ceftazidime/Avibactam for the Treatment of Infections in Children: A Case Series of Real-World Use. | Paediatr Drugs | 2025 | https://conductscience.org/library/papers/40019735 | PubMed |
| 5 | 32265601 | Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List. | J Pediatr Pharmacol Ther | 2020 | https://conductscience.org/library/papers/32265601 | PubMed |
| 6 | 22025597 | Extrapolation of adult data and other data in pediatric drug-development programs. | Pediatrics | 2011 | https://conductscience.org/library/papers/22025597 | PubMed |
| 7 | 38365226 | Real-world utilization of ceftazidime/avibactam among inpatients in the national Veterans Affairs Healthcare System. | Am J Health Syst Pharm | 2024 | https://conductscience.org/library/papers/38365226 | PubMed |
| 8 | 36375099 | Ceftolozane/Tazobactam and Ceftazidime/Avibactam: An Italian Multi-center Retrospective Analysis of Safety and Efficacy in Children With Hematologic Malignancies and Multi-drug Resistant Gram-negative Bacteria Infections. | Pediatr Infect Dis J | 2022 | https://conductscience.org/library/papers/36375099 | PubMed |
| 9 | 30909507 | A Review of the Clinical Pharmacokinetics of Polymyxin B. | Antibiotics (Basel) | 2019 | https://conductscience.org/library/papers/30909507 | PubMed |
| 10 | 39108079 | Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. | Clin Infect Dis | 2024 | https://conductscience.org/library/papers/39108079 | PubMed |
| 11 | 34901302 | Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections. | Open Forum Infect Dis | 2021 | https://conductscience.org/library/papers/34901302 | PubMed |
| 12 | 36763243 | The Use and Effectiveness of Ceftazidime-Avibactam in Real-World Clinical Practice: EZTEAM Study. | Infect Dis Ther | 2023 | https://conductscience.org/library/papers/36763243 | PubMed |
| 13 | 35065702 | Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. | Lancet | 2022 | https://conductscience.org/library/papers/35065702 | PubMed |
| 14 | 38927230 | Activity of Aztreonam/Avibactam and Recently Approved β-Lactamase Inhibitor Combinations against Enterobacterales and Pseudomonas aeruginosa from Intensive Care Unit and Non-Intensive Care Unit Patients. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/38927230 | PubMed |
| 15 | 25649155 | AKI in hospitalized children: comparing the pRIFLE, AKIN, and KDIGO definitions. | Clin J Am Soc Nephrol | 2015 | https://conductscience.org/library/papers/25649155 | PubMed |
| 16 | 33289506 | Understanding Pediatric Drug Lag Time: Review of Selected Drug Package Inserts. | J Pediatric Infect Dis Soc | 2021 | https://conductscience.org/library/papers/33289506 | PubMed |
| 17 | 35241917 | Ceftazidime/Avibactam versus Polymyxin B in the Challenge of Carbapenem-Resistant Pseudomonas aeruginosa Infection. | Infect Drug Resist | 2022 | https://conductscience.org/library/papers/35241917 | PubMed |
| 18 | 34430671 | Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa. | Open Forum Infect Dis | 2021 | https://conductscience.org/library/papers/34430671 | PubMed |
| 19 | 11389297 | Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. | Pediatrics | 2001 | https://conductscience.org/library/papers/11389297 | PubMed |
| 20 | 39847495 | Suggested Dosing of Select Beta-lactam Agents for the Treatment of Antimicrobial-Resistant Gram-Negative Infections in Children. | J Pediatric Infect Dis Soc | 2025 | https://conductscience.org/library/papers/39847495 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42016367
GET https://conductscience.org/api/papers/v1/42016367/authors?page=2